Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors.

[1]  M. Boyd,et al.  Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate, and ovarian tumors. , 1988, Cancer research.

[2]  M. Boyd,et al.  Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. , 1988, Cancer research.

[3]  M. Boyd,et al.  Evidence for thromboxane biosynthesis in established cell lines derived from human lung adenocarcinomas. , 1988, Cancer research.

[4]  D A Scudiero,et al.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.

[5]  M. Boyd,et al.  Metabolism of arachidonic acid in human lung cancer cell lines. , 1987, Cancer research.

[6]  M. Young,et al.  Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells. , 1987, Cancer research.

[7]  E. Bleecker,et al.  Profiling of prostaglandin biosynthesis in biopsy fragments of human lung carcinomas and normal human lung by capillary gas chromatography-negative ion chemical ionization mass spectrometry. , 1986, Prostaglandins.

[8]  J. Minna,et al.  Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. , 1986, Cancer research.

[9]  A. Gazdar,et al.  Cell culture methods for human lung cancer. , 1986, Cancer genetics and cytogenetics.

[10]  A. Gazdar,et al.  Preferential metabolism of N-nitrosodiethylamine by two cell lines derived from human pulmonary adenocarcinomas. , 1986, Carcinogenesis.

[11]  E. C. Klein,et al.  Stability and utility of the unique human small cell carcinoma line SHP-77. , 1985, Cancer research.

[12]  G. Bepler,et al.  Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.

[13]  T. Bauknecht,et al.  Formation of prostaglandins by ovarian carcinomas. , 1985, Prostaglandins.

[14]  G. Sorenson,et al.  Cytogenetics of small cell carcinoma of the lung. , 1984, Cancer genetics and cytogenetics.

[15]  J. Sheller,et al.  Arachidonic acid metabolites in the healthy and diseased lung. , 1984, The American journal of the medical sciences.

[16]  A. Gazdar,et al.  “Low grade” mucoepidermoid carcinoma of the bronchus with “high grade” biological behavior , 1983, Cancer.

[17]  F. Bettens,et al.  Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. , 1983, Journal of immunology.

[18]  Bonnie F. Sloane,et al.  Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis. , 1983, Biochemical pharmacology.

[19]  W. Whimster,et al.  Prostaglandins and human lung carcinomas. , 1982, British Journal of Cancer.

[20]  P. Alexander.  Prostaglandins and cancer , 1982, Nature.

[21]  T. Slaga,et al.  Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. , 1982, Carcinogenesis.

[22]  M. Young,et al.  Enhancement in immunity of tumor bearing mice by immunization against prostaglandin E2. , 1982, Immunological communications.

[23]  W. Hubbard,et al.  Preparation of deuterated arachidonic acid. , 1981, Prostaglandins.

[24]  L. Marnett,et al.  Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. , 1981, Prostaglandins.

[25]  S. Russell,et al.  Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E. , 1981, Journal of immunology.

[26]  T. Slaga,et al.  Modulation of prostaglandin synthesis and tumor promotion , 1981 .

[27]  L. Levine.  Arachidonic acid transformation and tumor production. , 1981, Advances in cancer research.

[28]  J. Minna,et al.  Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. , 1980, Cancer research.

[29]  R. Herberman,et al.  Inhibition of murine natural killer cell activity by prostaglandins. , 1980, Journal of immunology.

[30]  J. Jacquemier,et al.  Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. , 1980, Journal of the National Cancer Institute.

[31]  G. Sorenson,et al.  Isolation and growth characteristics of continuous cell lines from small‐cell carcinoma of the lung , 1980, Cancer.

[32]  A. Verma,et al.  Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. , 1980, Cancer research.

[33]  E. Bresnick,et al.  Epidermal prostaglandins after topical application of a tumor promotor. , 1979, Cancer letters.

[34]  A. Bennett.  Prostaglandins and Cancer , 1979 .

[35]  S. Karim.  Practical Applications of Prostaglandins and their Synthesis Inhibitors , 1979, Advances in Prostaglandin Research.

[36]  E. Fisher,et al.  A new in vitro cell line established from human large cell variant of oat cell lung cancer. , 1978, Cancer research.

[37]  T. Martin,et al.  PROSTAGLANDINS AND BREAST CANCER , 1977, The Lancet.

[38]  P. Hedqvist,et al.  Aspects of Prostaglandin Function in the Lung , 1977 .

[39]  J. Oates,et al.  Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. , 1975, The New England journal of medicine.

[40]  R. P. Robertson,et al.  Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma. , 1975, The Journal of clinical endocrinology and metabolism.

[41]  J. Fogh,et al.  New Human Tumor Cell Lines , 1975 .

[42]  S. Aaronson,et al.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. , 1973, Journal of the National Cancer Institute.